Clinical Trial Update: Dose Range Finding Study of Fedovapagon in Men With Nocturia [Phase 2]

View source ↗

Summary

Phase 2 dose-range finding study of Fedovapagon in men with nocturia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• Fedovapagon

Snippet

Sponsor: Vantia Ltd | Conditions: Nocturia | Phase 2 | Status: COMPLETED